Literature DB >> 6416577

Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.

M L Fletcher, J M Trowell, J Craske, K Pavier, C R Rizza.   

Abstract

Thirty patients who had not previously received treatment with factor VIII concentrate or who had been treated only infrequently with factor VIII concentrate were studied after a transfusion of factor VIII. Tests of liver function were performed frequently. Four patients had evidence of chronic liver disease before transfusion. In 17 of the remaining 26 patients serum transaminase activities became raised and 10 patients developed jaundice. All of the nine patients who had not previously received factor VIII transfusion developed non-A non-B hepatitis. Four out of 10 patients followed up for a year had persisting abnormalities of liver function. The pattern of illness suggests that more than one serotype of non-A non-B hepatitis virus may be transmitted by factor VIII concentrate prepared by the National Health Service from volunteer donors in the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416577      PMCID: PMC1549875          DOI: 10.1136/bmj.287.6407.1754

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

2.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

3.  Jaundice and antibodies directed against factors 8 and 9 in patients treated for haemophilia or Christmas disease in the United Kingdom.

Authors:  R Biggs
Journal:  Br J Haematol       Date:  1974-03       Impact factor: 6.998

4.  Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis.

Authors:  J Craske; R J Spooner; E M Vandervelde
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

5.  Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders.

Authors:  M Bamber; A Murray; B A Arborgh; P J Scheuer; P B Kernoff; H C Thomas; S Sherlock
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

6.  Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees.

Authors:  H Yoshizawa; Y Itoh; S Iwakiri; K Kitajima; A Tanaka; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

7.  Hepatitis B surface antigen testing: the Blood Products Laboratory radioimmunoassay (BPL/RIA) system.

Authors:  R S Lane
Journal:  Med Lab Sci       Date:  1981-10

8.  Radioimmunoassay detection of hepatitis type B antigen. A prospective study in blood donors and recipients.

Authors:  G L Giorgini; F B Hollinger; L Leduc; S Issarescu; J George; A Blackman; W R Thayer
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

9.  Commercial factor VIII associated hepatitis, 1974-75, in the United Kingdom: a retrospective survey.

Authors:  J Craske; P Kirk; B Cohen; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1978-06

10.  Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies.

Authors:  D W Bradley; J E Maynard; E H Cook; J W Ebert; C R Gravelle; K N Tsiquaye; H Kessler; A J Zuckerman; M F Miller; C Ling; L R Overby
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

View more
  24 in total

Review 1.  Management of hemophilia in developing countries.

Authors:  R Kashyap; V P Choudhry
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

Review 2.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

3.  Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.

Authors:  R K Chaudhary; C MacLean
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Authors:  M G Ghany; C Leissinger; R Lagier; R Sanchez-Pescador; A S Lok
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 5.  Haemophilic arthritis.

Authors:  R Madhok; J York; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

Review 6.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

7.  Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.

Authors:  Mingdong Zhang; Philip S Rosenberg; Deborah L Brown; Liliana Preiss; Barbara A Konkle; M Elaine Eyster; James J Goedert
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

8.  C-C chemokines, pivotal in protection against HIV type 1 infection.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; S J O'Brien; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Safety trial of heated factor VIII concentrate (8Y).

Authors:  K J Pasi; F G Hill
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

10.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.